Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;101(2):243-249.
doi: 10.1002/ccd.30516. Epub 2022 Dec 9.

Novel application of intravascular lithotripsy in stent under-expansion: A single-center experience

Affiliations

Novel application of intravascular lithotripsy in stent under-expansion: A single-center experience

Jonathan Hinton et al. Catheter Cardiovasc Interv. 2023 Feb.

Abstract

Introduction: Stent under-expansion due to calcification is associated with a less durable result. The development of intravascular lithotripsy (IVL) has provided clinicians with a readily available, simple-to-use treatment option for coronary calcification, but the use of IVL within a previously stented segment is currently off-license. There are, however, developing data suggesting that the use of IVL can be an effective treatment option for patients with calcific stent under-expansion.

Method: This was a single-center study of all patients treated with IVL for calcific stent under-expansion between January 2019 and June 2021. The impact of IVL on quantitative coronary angiography (QCA) stenosis and on the minimal stent area (MSA) derived from intracoronary imaging were recorded. The presence of periprocedural complications and adverse cardiovascular events was obtained from the clinical record during the study timeframe.

Results: Thirty-nine patients underwent IVL for calcific stent under-expansion during the study time frame with one patient treated with more than one lesion in the same session. In all lesions, there was an improvement in the QCA stenosis with 37 (92.5%) having a residual stenosis of ≤30%. The mean QCA stenosis pre-IVL was 68 ± 21% and following IVL the mean QCA was 18 ± 9% (p < 0.001). In all lesions, there was an improvement in the MSA, with 26 (92.9%) achieving an MSA of more than 4.5 mm2. The mean MSA pre-IVL was 3.88 ± 1.51 mm2 and following IVL the mean MSA was 7.41 ± 2.34 mm2 (p < 0.001). There were no major procedural complications. Over a mean follow-up of 506 ± 277 days, one patient died from ventricular arrhythmia but there were no other major adverse cardiovascular events.

Conclusion: This single-center study demonstrates that IVL is a safe and effective treatment for calcific stent under-expansion with good medium-term results.

Keywords: acute coronary syndrome; complex coronary revascularization; coronary calcification; drug‐eluting stent.

PubMed Disclaimer

References

REFERENCES

    1. Guedeney P, Claessen BE, Mehran R, et al. Coronary calcification and long‐term outcomes according to drug‐eluting stent generation. JACC Cardiovasc Interv. 2020;13(12):1417‐1428.
    1. Tada T, Miura K, Ikuta A, et al. Prevalence, predictors, and outcomes of in‐stent restenosis with calcified nodules. EuroIntervention. 2022;17(16):1352‐1361.
    1. Choi SY, Maehara A, Cristea E, et al. Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS‐AMI Trial IVUS substudy). Am J Cardiol. 2012;109(4):455‐460.
    1. Nishi T, Kitahara H, Fujimoto Y, et al. Comparison of 3‐dimensional and 2‐dimensional quantitative coronary angiography and intravascular ultrasound for functional assessment of coronary lesions. J Cardiol. 2017;69(1):280‐286.
    1. Natalia M, Forero T, Daemen J. The coronary intravascular lithotripsy system. Interv Cardiol Rev. 2019;14(3):174‐181.

LinkOut - more resources